Cargando…
Prostate Cancer in Transplant Receivers—A Narrative Review on Oncological Outcomes
Prostate cancer (PCa) is a low tumor mutational burden (TMB) cancer with a poor response to immunotherapy. Nonetheless, immunotherapy can be useful, especially in metastatic castration-resistant PCa (mCRPC). Increased cytotoxic T lymphocytes (CTLs) density is correlated with a shorter overall surviv...
Autores principales: | Hanusz, Karolina, Domański, Piotr, Strojec, Kacper, Zapała, Piotr, Zapała, Łukasz, Radziszewski, Piotr |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10669184/ https://www.ncbi.nlm.nih.gov/pubmed/38001942 http://dx.doi.org/10.3390/biomedicines11112941 |
Ejemplares similares
-
The Role of Microbial Factors in Prostate Cancer Development—An Up-to-Date Review
por: Garbas, Karolina, et al.
Publicado: (2021) -
Oncological outcomes of high-grade T1 non-muscle-invasive bladder cancer treatment in octogenarians
por: Ślusarczyk, Aleksander, et al.
Publicado: (2021) -
The impact of smoking on recurrence and progression of non-muscle invasive bladder cancer: a systematic review and meta-analysis
por: Ślusarczyk, Aleksander, et al.
Publicado: (2022) -
External validation of a magnetic resonance imaging-based algorithm for prediction of side-specific extracapsular extension in prostate cancer
por: Zapała, Piotr, et al.
Publicado: (2021) -
Cancer-Specific Survival of Patients with Non-Muscle-Invasive Bladder Cancer: A Population-Based Analysis
por: Ślusarczyk, Aleksander, et al.
Publicado: (2023)